CytoDyn's (CYDY) high-energy CEO Nadir Pourhassan [NP] has been in his element in the fast-paced news cycle attendant upon all things COVID-19. Today, as I write on 4/7/20, he has responded to both a Charles Payne Fox Business interview along with another in his series of regular Proactive YouTube interviews, both interviews promoting leronlimab's recent COVID-19 achievements.
Leronlimab has staked a claim as a possible therapy for treatment of COVID-19
When I first noticed that CytoDyn was laying a claim to leronlimab as a COVID-19 (then known by the name Novel Coronavirus 2019-nCov)